Karin Hoogendoorn
Director/Board Member at Centre For Advanced Medical Products
Profile
Karin Hoogendoorn is currently a Director at the Centre For Advanced Medical Products.
Previously, she worked as an Associate Director at Novartis AG and Janssen Biologics BV.
She also served as a Director at Idogen AB and an Independent Director at Elicera Therapeutics AB.
Additionally, she was the Head of Chemistry, Manufacturing & Controls at Mendus AB.
Dr. Hoogendoorn holds a graduate degree from the University of Leiden and a doctorate degree from the University of Utrecht.
Karin Hoogendoorn active positions
Companies | Position | Start |
---|---|---|
Centre For Advanced Medical Products | Director/Board Member | - |
Former positions of Karin Hoogendoorn
Companies | Position | End |
---|---|---|
IDOGEN AB (PUBL) | Director/Board Member | 11/05/2020 |
ELICERA THERAPEUTICS AB | Director/Board Member | - |
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Corporate Officer/Principal | - |
NOVARTIS AG | Corporate Officer/Principal | - |
MENDUS AB | Corporate Officer/Principal | - |
Training of Karin Hoogendoorn
University of Leiden | Graduate Degree |
University of Utrecht | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
MENDUS AB | Health Technology |
IDOGEN AB (PUBL) | Health Technology |
NOVARTIS AG | Health Technology |
ELICERA THERAPEUTICS AB | Health Technology |
Private companies | 2 |
---|---|
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Health Technology |
Centre For Advanced Medical Products |
- Stock Market
- Insiders
- Karin Hoogendoorn